Multiplex Assay Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) ,etc. by FLIA (Flow Luminescence Immunoassay)
Ref: CC-LMP853Hu
NB; DAN; NO3; DAND1; Differential Screening-Selected Gene Aberrant In Neuroblastoma; DAN domain family member 1
Información del producto
Especificidad:
This assay has high sensitivity and excellent specificity for detection of Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.
Información adicional
Applications
FLIA Kit for Antigen Detection.
Detection Range
0.01-10ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.003 ng/mL
Specificity
Research Area
Tumor immunity
Organism species
Homo sapiens (Human)
Alternative Names
NB
Item Name
Neuroblastoma, Suppression Of Tumorigenicity 1
Assay Length
3h
Method
Double-antibody Sandwich
Sample Type
Tissue homogenates, cell lysates and other biological fluids.
Format
48T, 96T, 96T×5, 96T×10, 96T×100
Test Principle
Analyte-specific antibodies are pre-coated onto color-coded microparticles. Microparticles, standards, and samples are pipetted into wells and the immobilized antibodies bind the analytes of interest. After washing away any unbound substances, a biotinyla
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment
UniProt ID
P41271